VFA
MED icon

Virtus Fund Advisers’s Medifast MED Stock Holding History

Virtus Fund Advisers’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,121
Closed -$34K – 1593
2014
Q2 		$34K Buy
+1,121
New +$34.9K ﹤0.01% 2110

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
GGPE
Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtus Fund Advisers's MED Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Medifast (MED) in Q3 2014, closing a stake of 1,121 shares — an estimated $34K sold.

Virtus Fund Advisers first reported a position in MED in Q2 2014 and held it in 1 quarter. The position peaked at $34K in Q2 2014. 124 funds tracked by Wall St. Rank hold MED as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Medifast position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,121 Medifast shares in Q3 2014, an estimated $34K.
  • Virtus Fund Advisers first reported a position in Medifast in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Medifast position peaked at $34K in Q2 2014.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.